{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "10731806",
  "DateCompleted": {
    "Year": "2000",
    "Month": "04",
    "Day": "26"
  },
  "DateRevised": {
    "Year": "2008",
    "Month": "11",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "fre"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0035-2640",
      "JournalIssue": {
        "Volume": "49",
        "Issue": "20",
        "PubDate": {
          "Year": "1999",
          "Month": "Dec",
          "Day": "15"
        }
      },
      "Title": "La Revue du praticien",
      "ISOAbbreviation": "Rev Prat"
    },
    "ArticleTitle": "[Cytomegalovirus (CMV)].",
    "Pagination": {
      "StartPage": "2222",
      "EndPage": "2226",
      "MedlinePgn": "2222-6"
    },
    "Abstract": {
      "AbstractText": [
        "Human cytomegalovirus (CMV) is an ubiquitous agent. CMV infection is a common, usually subclinical world wide infection with a tendency for virulence in congenitally-infected infants and immunosuppressed patients including allograft recipients and patients with AIDS. Anti-CMV drugs are used for the treatment of severe infections in immunosuppressed patients. Developments of vaccine to protect pregnant women from primary infection are in progress."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Service de bact\u00e9riologie-virologie H\u00f4pital Lariboisi\u00e8re, Paris."
          }
        ],
        "LastName": "Mazeron",
        "ForeName": "M C",
        "Initials": "MC"
      }
    ],
    "PublicationTypeList": [
      "English Abstract",
      "Journal Article"
    ],
    "VernacularTitle": "Cytom\u00e9galovirus (CMV)."
  },
  "MedlineJournalInfo": {
    "Country": "France",
    "MedlineTA": "Rev Prat",
    "NlmUniqueID": "0404334",
    "ISSNLinking": "0035-2640"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antiviral Agents"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antiviral Agents"
    },
    {
      "QualifierName": [
        "immunology",
        "pathogenicity"
      ],
      "DescriptorName": "Cytomegalovirus"
    },
    {
      "QualifierName": [
        "drug therapy",
        "immunology",
        "pathology"
      ],
      "DescriptorName": "Cytomegalovirus Infections"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Immunocompromised Host"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Incidence"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Infant, Newborn"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Infectious Disease Transmission, Vertical"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pregnancy"
    },
    {
      "QualifierName": [
        "prevention & control",
        "virology"
      ],
      "DescriptorName": "Pregnancy Complications, Infectious"
    }
  ]
}